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Results: The	 addition	 of	 a	 kidney	 to	 a	 limb	 perfusion	 circuit	 resulted	 in	 the	
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the	 first	 year.1	 VCA	 rejection	 is	 complex,	 involving	 the	
donor	and	recipient	immune	compartment.	The	graft	in-







such,	 injury	 is	 incurred	 during	 preservation,	 transplan-
tation	 and	 following	 reperfusion,	 and	 collectively	 this	 is	
considered	a	potent	catalyst	for	rejection.6
The	 gold	 standard	 approach	 to	 VCA	 preservation	 is	
static	 cold	 storage	 (SCS),	 where	 the	 vessels	 of	 the	 graft	






normothermic	 perfusion	 (EVNP)	 has	 satisfied	 the	 need	
to	better	preserve	solid	organs,	whilst	enabling	functional	
evaluation.	This	technology	is	being	rapidly	adopted	into	
the	 clinical	 setting	 for	 solid	 organ	 transplantation,	 with	
several	 studies	 demonstrating	 superior	 outcomes	 com-
pared	to	SCS.8,9	However,	the	application	of	this	technol-
ogy	 in	 VCA	 has	 been	 purely	 experimental	 to	 date,	 with	
several	 groups	 developing	 perfusion	 protocols	 for	 VCA	
preservation.10-	17	We	have	 recently	 reported	 that	normo-




A	 common,	 and	 somewhat	 speculative	 limitation	
to	 successful	 VCA	 perfusion	 relates	 to	 the	 perpetually	
increasing	metabolic	by-	products	and	toxins,	when	com-
pared	 with	 solid	 organ	 perfusion.15-	18	 Increasing	 lactate	
levels	beyond	physiological	range	are	observed	in	all	pub-
lished	 cases	 (where	 data	 is	 presented).	 We	 hypothesize	
that	 regulating	 key	 metabolites	 will	 improve	 perfusion	
biochemistry	 by	 preventing	 imbalances	 associated	 with	
hypo-	perfusion	in	the	in	vivo	setting.	However,	selectively	
removing	 metabolites	 remains	 a	 challenge.	 Attempts	 to	
replace	 perfusate	 throughout	 limb	 perfusion	 have	 been	
evaluated,19	 but	 this	 is	 laborious,	 time	 consuming	 and	
non-	specific.	Hemodialysis	can	be	used	to	regulate	hema-
tological,	biochemical	and	acid-	base	instability	but	this	is	
reliant	 upon	 high	 performance	 hollow	 fiber	 membranes	
that	target	specific	solutes	based	solely	on	size.	As	such,	





ate	 the	 impact	 of	 renal	 hemofiltration	 on	 perfusion	 bio-
chemistry	 and	 hemodynamics.	 Using	 this	 experimental	
approach,	our	goal	was	to	determine	if	renal	hemofiltra-
tion	improves	graft	perfusion,	which	would	highlight	the	
need	 to	 use	 clinically	 approved,	 advanced	 hemodialysis	
systems	during	ex-	vivo	machine	perfusion	of	the	limb.









iU	 unfractionated	 heparin	 (Fannin,	 Northamptonshire,	
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incision	was	made	and	both	kidneys	were	excised	en	bloc.	
Kidneys	were	dissected	free	from	the	aorta,	ensuring	max-










warm	 ischemia	 (time	 of	 death	 after	 exsanguination	 until	
the	 start	of	 cold	preservation	 flush).	Once	cannulated,	 the	
kidney	was	flushed	with	20	ml	of	glycerine	trinitrate	(GTN,	











lution	 supplemented	 with	 bovine	 serum	 albumin	 (Sigma	
Aldrich,	Dorset,	UK),	50	ml	of	sodium	bicarbonate	(8.4%),	
40	ml	20%	mannitol	(Baxter	Healthcare,	Norfolk,	UK),	13.2	
mg	 dexamethasone	 (Hameln,	 Gloucester,	 UK),	 500	 mg	
Meropenem	 (Hikma,	 Portugal),	 4000	 iU	 unfractionated	
Heparin	 and	 30	 ml	 15%	 glucose	 (Sigma	 Aldrich,	 Dorset,	




















to	 one	 perfusion	 circuit	 at	 random,	 via	 the	 renal	 artery	
cannula	 (see	 Figure	 S1	 for	 a	 schematic	 of	 the	 perfusion	
circuits).	 The	 target	 arterial	 pressure	 was	 initially	 set	 to	
55  mm	 Hg	 and	 then	 gradually	 increased	 by	 5  mm	 Hg	
every	 5  min	 to	 reach	 a	 target	 pressure	 of	 75  mm	 Hg,	 to	
prevent	endothelial	shearing.








limb-	kidney	 (LK)	 perfusion),	 or	 perfused	 on	 a	 separate	
circuit	 in	 isolation	 (limb	 only,	 LO—	See	 Figure	 S2	 for	 a	
Gantt	chart	of	the	protocol).	Limbs	were	perfused	via	the	
brachial	and	radial	collateral	arteries	to	achieve	maximal	
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interaction	between	these	were	included	as	within-	subject	
effects.	 p	 Values	 were	 calculated	 using	 the	 Greenhouse-	
Geisser	approach.	A	subgroup	analysis	including	only	the	
first	 hour	 of	 measurements	 from	 each	 experiment	 was	
also	performed.














and	 mounted	 onto	 Superfrost™	 positively	 charged	 mi-
croscope	slides	(Thermo-	Scientific,	Germany).	The	slides	
were	 de-	paraffinized	 and	 stained	 with	 hematoxylin	 and	
Eosin	 Y	 (H&E)	 using	 the	 Leica	 Autostainer	 XL	 (Leica	
Biosystems,	Nussloch,	Germany).	All	slides	were	assessed	






available	 porcine	 13-	plex	 magnetic	 bead	 panel	 (Merck	




Extracellular	 genomic	 (gDNA)	 and	 mitochondrial	 DNA	
(mtDNA)	 was	 quantified	 using	 the	 appropriate	 primers	
(Sigma	Aldrich,	Dorset,	UK).	To	 identify	gDNA	primers	
to	 the	 housekeeping	 gene	 glyceraldehyde-	3-	phosphate	
(GAPDH)	were	used	and	primers	specific	for	cytochrome	
B	 were	 used	 to	 quantify	 mtDNA.	 A	 MicroAmp	 Optical	
348-	well	 reaction	 plate	 was	 used,	 and	 qPCR	 was	 per-
formed	 using	 a	 QuantStudio	 12-	flex	 system	 with	 Power	
SYBR	green	PCR	master	mix	(Life	Technologies,	Paisley,	
UK).






test.	 For	 comparison	 of	 multiple	 variables	 over	 time	 in	
each	 group	 two-	way	 ANOVAs	 were	 used.	 Independent	
samples	t-	test	or	the	Mann	Whitney	U	test	were	then	uti-
lized	for	a	direct	comparison	between	single	time-	points,	
dependent	 on	 data	 distribution.	 Pearson's	 correlation	
coefficient	 was	 utilized	 to	 assess	 correlations.	 Data	 was	
considered	significantly	different	if	a	p-	value	of	≤	.05	was	
observed.
3 |  RESULTS
3.1 | Procurement




min)	and	cold	 ischemia	 time	 (133.4 ± 14.7	min)	 for	 the	
randomized	perfused	kidney	were	also	recorded.









meaning	 flow	 was	 determined	 as	 a	 total	 for	 both	 the	
kidney	 and	 the	 limb	 (see	 Figure	 S1).	 The	 significant	
increase	 in	 flow	 was	 therefore	 likely	 to	 be	 an	 artefact	
of	the	combined	vascular	reservoir	of	the	limb	and	the	
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kidney,	 rather	 than	 improved	hemodynamics.	To	eval-






Hg	 via	 manually	 controlling	 pump	 speed	 (Figure  1B).	
Vascular	 resistance	 was	 calculated	 using	 the	 MAP	 of	
the	circuit	divided	by	 flow	rate	 (for	LK	this	was	deter-
mined	 as	 a	 total	 for	 the	 limb	 and	 kidney	 combined).	
Interestingly,	vascular	resistance	was	lower	throughout	
the	experiment	in	LK	perfusion	(p = .0416,	Figure 1C).
3.3 | Limb histology
Muscle,	skin,	and	vessel	biopsies	were	independently	re-
viewed	 and	 graded	 using	 the	 HISS	 grading	 by	 a	 clinical	
Histopathologist.	 In	 both	 groups	 tissue	 architecture	 was	
well	 preserved	 at	 6  h,	 with	 no	 differences	 observed	 be-
tween	either	limb.






For	 the	 limbs,	 trends	 over	 time	 in	 temperature	 variabil-








3.5 | Perfusate biochemistry
Lactate	 remained	 low	 and	 stable	 in	 the	 initiation	 phase	
(1	 h	 of	 kidney	 perfusion)	 of	 LK	 perfusion.	 Following	
F I G U R E  1  Hemodynamic	differences	between	LO	and	LK	perfusion.	(A)	Flow	rate	in	ml/min,	(B)	mean	arterial	pressure	(mm	Hg),	
(C)	mean	vascular	resistance	(mm	Hg/min/ml)	in	LO	vs	LK	perfusion,	and	(D)	renal	blood	flow	during	LK	perfusion
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attachment	 of	 the	 limb,	 lactate	 increased	 rapidly	 from	
(3.3  mmol/L  ±  5.2	 to	 10.9  mmol/L  ±  3.5	 within	 1	 h	 of	
LK	perfusion,	Figure 3A).	Lactate	levels	continued	to	de-
crease	throughout	perfusion,	with	a	final	concentration	of	
7.5  mmol/L  ±  1.7	 at	 6  h.	 Conversely,	 lactate	 levels	 rap-
idly	increased	to	14.6 mmol/L ± 2.2	during	LO	perfusion,	
and	remained	high	throughout.	The	end	concentration	of	
lactate	 during	 LO	 was	 13.8  mmol/L  ±  3.7.	 Using	 2-	way	
ANOVA,	lactate	was	significantly	lower	in	LK	compared	
to	LO	(p = .0048).	Taking	each	timepoint	of	perfusion	as	









ing	 lactate	 to	 glucose	 conversion	 was	 adequate	 for	 both	
tissues	(Figure 3B).	Conversely	in	the	LO	circuit,	glucose	





Given	 that	 hyperlactatemia	 disrupts	 sodium	 bicarbon-
ate	 recycling,	 we	 then	 evaluated	 if	 stable	 lactate	 resulted	
in	physiological	levels	of	bicarbonate	during	LK	perfusion.	
This	 was	 comparable	 to	 lactate,	 with	 bicarbonate	 levels	
F I G U R E  2  Perfusion	homogeneity	based	on	topical	temperature	via	infrared	(IR)	imaging.	(A)	Representative	IR	images	of	the	kidney	
perfused	alone	in	the	first	hour	and	(B)	hour	3	and	6	following	attachment	of	the	limb.	(C)	Standard	deviation	of	surface	temperatures	
collected	from	multiple	regions	of	the	limb	and	(D)	representative	IR	images	of	LO	versus	LK	perfusion
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remaining	within	physiological	range	over	the	6 h	of	perfu-
sion	(Figure 3C).	Conversely,	bicarbonate	was	only	within	
physiological	 range	 in	 the	 first	 hour	 of	 LO	 perfusion.	 In	
keeping	with	lactate,	this	was	statistically	significant	from	
3-	6 h	of	perfusion	between	the	groups.	As	bicarbonate	rep-


















between	 these	 parameters.	 In	 all	 cases,	 bicarbonate	 and	
base	 positively	 correlated	 with	 pH	 in	 both	 LO	 and	 LK,	
whereas	 lactate	 was	 inversely	 correlative	 (Table  1),	 sug-
gesting	metabolic	acidosis	was	present	in	LO	but	not	LK.





adequate	 function	of	 the	kidney	via	 the	maintenance	of	
appropriate	sodium	levels.
F I G U R E  2  (Contiuned)
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3.6 | Inflammatory profile
Nine	 of	 the	 thirteen	 cytokines	 and	 chemokines	 as-
sessed	 were	 detected	 within	 the	 perfusate,	 increas-
ing	over	time	in	both	groups.	However,	only	cytokine	
members	of	the	interleukin-	1	family	were	different	be-
tween	groups.	These	 included	 IL-	1α,	 IL-	1β	and	 IL-	18	
(Figure  5).	 We	 then	 determined	 urinary	 concentra-
tions	of	IL-	1α,	IL-	1β	and	IL-	18	to	assess	if	urinary	se-





F I G U R E  3  Perfusate	biochemistry.	(A)	Lactate,	(B)	glucose,	(C)	sodium	bicarbonate,	and	(D)	base	(all	in	mmol/L),	and	(E)	pH
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whereas	 mtDNA	 remained	 undetectable	 throughout	
the	experiment	in	both	groups.
4 |  DISCUSSION
We	 have	 recently	 demonstrated	 that	 normothermic	 ma-
chine	 perfusion	 results	 in	 improved	 VCA	 preservation	
when	 compared	 to	 SCS.10	 However,	 a	 major	 obstacle	 to	
successful	NMP	of	 the	 limb	 is	metabolic	acidosis	due	 to	
a	 persistent	 increase	 in	 lactate.	 Metabolic	 acidosis	 dis-














at	 the	 start	 of	 perfusion,	 with	 continuous	 infusions	 and	
additional	boluses	to	control	base	deficit.11-	18	Bicarbonate	
supplementation	 rapidly	 stabilizes	 base,	 but	 often	 into	
base	 excess,	 which	 in	 turn	 may	 be	 reduced	 via	 increas-
ing	 CO2	 concentrations	 in	 the	 circuit	 oxygenator.	 The	





T A B L E  1  Correlations	between	
bicarbonate,	base	deficit/excess	and	
lactate	with	perfusate	pH
F I G U R E  4  Perfusate	electrolyte	composition.	(A)	Potassium,	(B)	calcium	and	(C)	sodium	concentrations	(in	mmol/L)	over	time	in	LO	
versus	LK	perfusion
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relationship	 between	 CO2,	 bicarbonate,	 lactate,	 glucose	
and	pH	is	highly	complex,	as	acidosis	drives	electrolytes	
from	the	muscle	leading	to	hyperkalemia.	Several	groups	
control	 this	 with	 glucose	 and	 insulin	 supplementation,	
creating	a	pendulous	scenario	incomparable	to	the	stable	
physiological	control	of	these	systems	in	vivo.	The	net	re-
sult	 of	 this	 approach	 is	 a	 disrupted	 environment,	 which	
again	is	a	common	feature	of	VCA	perfusion.	Despite	sig-





addition	 of	 superior	 hemofiltration	 to	 a	 VCA	 perfusion	
would	be	of	benefit	via	renal	gluconeogenesis	and	lactate	
conversion.	 However,	 current	 hemofiltration	 devices	 are	
inadequate	 in	 maintaining	 perfusion	 biochemistry,	 as	
simply	removing	substances	below	a	specific	size	from	the	
circuit	would	not	support	metabolic	regulation	and	con-
trol	 pH.	 Indeed,	 hemofiltration	 inherently	 removes	 key	
substances	 that	 are	 essential	 for	 perfusion	 homeostasis,	







celerates	 lactate	 conversion	 during	 acidosis,28	 pH	 would	
be	stabilized.




occurred	 with	 a	 concurrent	 increase	 in	 glucose	 (despite	





describes	 the	 process	 where	 lactate	 diffused	 from	 skele-
tal	 muscle	 during	 anaerobic	 metabolism	 is	 absorbed	 by	
the	renal	cortex	and	converted	to	glucose	via	pyruvate.30	
The	 glucose	 is	 then	 diffused	 from	 the	 renal	 cortex	 and	
F I G U R E  5  Perfusate	cytokine	profile.	(A)	IL-	1α,	(B)	IL-	1β	and	(C)	IL-	18	concentration	(ng/ml)	in	the	perfusate	of	LO	and	LK	circuits






haps	more	critical	 to	VCA	perfusion,	 is	 the	 requirement	
for	sufficient	levels	of	the	Cori	cycle	by-	product,	pyruvate	
within	the	perfusate.	Pyruvate	is	converted	to	acetyl-	CoA	
and	CO2	via	alanine	conversion,	 resulting	 in	 the	perma-







parameters.	 Logically,	 a	 base	 deficit	 highlights	 an	 acid/
base	derangement	that	would	likely	result	 in	an	acidotic	
environment.	This	was	observed	in	LO	perfusion,	where	
pH	 of	 the	 perfusate	 was	 acidotic.	 Importantly,	 neutral	
pH	was	preserved	 throughout	LK	perfusion.	 It	 therefore	






the	 duration	 of	 perfusion,	 and	 interestingly,	 found	 that	





levels	 within	 the	 urine	 were	 minimal,	 suggesting	 other	
F I G U R E  6  Urinary	cytokine	profile.	(A)	IL-	1α,	(B)	IL-	1β	and	(C)	IL-	18	concentration	(ng/ml)	in	urine	from	the	LK	circuit
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mechanisms	 were	 involved.	 It	 is	 therefore	 more	 likely	
that	the	acidotic	environment	observed	in	the	LO	circuit	
is	 responsible	 for	 the	 increase	 in	 IL-	1	 family	 cytokines.	
There	 is	 evidence	 that	 NLRP3	 inflammasome	 activation	
occurs	 in	the	presence	of	acidosis,	 increasing	the	activa-






IL-	1α	 is	 not	 a	 direct	 substrate	 for	 the	 inflammasome	 ef-
fector	protease	caspase-	1,	but	is	cleaved	by	other	caspases	
and	 calpains.32,33	 There	 are	 thus	 a	 number	 of	 potential	
pathways	that	could	contribute	to	the	increase	in	IL-	1	fam-
ily	cytokines	observed	here.	Nonetheless,	the	IL-	1	family	
cytokines	 remained	 low	 during	 LK	 perfusion,	 but	 con-
tinually	 increased	during	LO.	Given	that	 IL-	1β	has	been	
identified	as	a	potential	biomarker	of	donor	organ	recon-
ditioning	 in	 other	 settings,	 and	 IL-	1β	 antagonists	 have	












future	 studies,	 independent	 flow	 and	 pressure	 monitors	
should	be	used	on	the	arterial	cannulas	to	the	kidney	and	
to	 the	 limb.	The	second	 limitation	 is	 that	we	did	not	 re-
cord	urine	production,	or	other	critical	markers	of	 renal	
function,	such	as	creatinine	clearance,	or	markers	of	renal	









fusion	hemodynamics	were	probably	 too	 subtle	 to	 show	
within	the	study	time	frame.	Based	on	thermal	imaging	of	
the	VCA,	the	homogeneity	of	perfusion	was	significantly	
better	 in	 LK	 compared	 to	 LO	 perfusion.	 This	 may	 be	 of	
relevance	given	that	lactic	acidosis	(type	A)	occurs	either	
















and	 currently	 unrealizable	 dilemma—	existing	 dialysis	
technologies	are	only	capable	of	isolating	molecules	based	
on	 physical	 characteristics	 alone,	 whereas	 the	 beneficial	
actions	 of	 the	 kidney	 during	VCA	 perfusion	 are	 exerted	
via	 biochemical	 processes	 that	 maintain	 “perfusate	 ho-
meostasis”,	 for	 which	 there	 are	 currently	 no	 existing	
technologies	or	approaches.	However,	the	benefit	of	trans-
membrane	 dialysis	 during	 perfusion	 of	 other	 organs	 for	
transplant	has	been	reported,	so	this	approach	should	be	
evaluated	during	VCA	perfusion.35	Alternatively,	replicat-
ing	 biochemical	 processes	 to	 support	 lactate	 conversion,	
gluconeogenesis,	 pyruvate	 production,	 and	 bicarbonate	
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